Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 7/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 5/20 | 0.40 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.40 |
| ▸ | KDR | P35968 | 3/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.40 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.40 |
| ▸ | CCR2 | P41597 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30501416 | 0.85 | IRAK4 (0.39) | NTSR1IRAK4ROCK2ROCK1FGFR3 | |
| SCHEMBL20598453 | 0.84 | IRAK4 (0.61) | NTSR1IRAK4ROCK2ROCK1 | |
| SCHEMBL30501405 | 0.79 | ROCK2 (0.39) | NTSR1IRAK4ROCK2ROCK1FGFR3 | |
| SCHEMBL30501321 | 0.78 | ROCK2 (0.36) | NTSR1IRAK4ROCK2ROCK1FGFR3 | |
| SCHEMBL20597991 | 0.74 | CSF1R (0.44) | IRAK4ROCK2ROCK1 | |
| SCHEMBL20598549 | 0.74 | CHEK1 (0.52) | IRAK4CHEK1 | |
| SCHEMBL20621607 | 0.72 | NTSR1 (0.45) | NTSR1CCR2 | |
| Hydrochloric Acid SCHEMBL28379487 | 0.71 | NTSR1 (0.45) | NTSR1CCR2 | |
| Hydrochloric Acid SCHEMBL20598024 | 0.71 | NTSR1 (0.44) | NTSR1CCR2 | |
| SCHEMBL20598773 | 0.68 | ALDH1A1 (0.57) | NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111032642-B | Kinase inhibitors and methods of making and using the same | 里格尔药品股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-111032642-B | Kinase inhibitors and methods of making and using the same | 里格尔药品股份有限公司 | 2023-07-18 | — | — | CN | disclosed |